tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RANI Stock Latest News

Rani Therapeutics Reports Q2 2025 Financial Results
Company AnnouncementsRani Therapeutics Reports Q2 2025 Financial Results
2M ago
RANI
Rani Therapeutics files $200M mixed securities shelf
PremiumThe Fly
Rani Therapeutics files $200M mixed securities shelf
2M ago
RANI
Rani Therapeutics Announces New Securities Purchase Agreement
PremiumCompany Announcements
Rani Therapeutics Announces New Securities Purchase Agreement
3M ago
8K
RANI
Rani Therapeutics prices 4.35M shares at 40c in registered direct offering
PremiumThe Fly
Rani Therapeutics prices 4.35M shares at 40c in registered direct offering
3M ago
RANI
Genelux appoints Eric Groen as general counsel, corporate secretary, CCO
PremiumThe Fly
Genelux appoints Eric Groen as general counsel, corporate secretary, CCO
3M ago
GNLX
RANI
Rani files to sell 13.16M shares of Class A common stock for holders
PremiumThe FlyRani files to sell 13.16M shares of Class A common stock for holders
3M ago
RANI
Rani Therapeutics Faces Nasdaq Non-Compliance Notice
Premium
Company Announcements
Rani Therapeutics Faces Nasdaq Non-Compliance Notice
3M ago
8K
RANI
Rani Therapeutics Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Rani Therapeutics Approves Key Proposals at Annual Meeting
4M ago
8K
RANI
Rani Therapeutics: Strategic Partnerships and Financial Strength Justify Buy Rating
PremiumRatings
Rani Therapeutics: Strategic Partnerships and Financial Strength Justify Buy Rating
5M ago
RANI
Rani Therapeutics Secures $4.3M via Series D Warrant
PremiumCompany Announcements
Rani Therapeutics Secures $4.3M via Series D Warrant
5M ago
8K
RANI
Rani Therapeutics announces research agreement with Chugai
PremiumThe Fly
Rani Therapeutics announces research agreement with Chugai
5M ago
RANI
Rani Therapeutics: Strategic Advancements in Obesity Treatment Justify Buy Rating
PremiumRatings
Rani Therapeutics: Strategic Advancements in Obesity Treatment Justify Buy Rating
5M ago
RANI
Rani Therapeutics price target lowered to $4 from $14 at Oppenheimer
PremiumThe FlyRani Therapeutics price target lowered to $4 from $14 at Oppenheimer
5M ago
RANI
Rani Therapeutics Highlights Promising Preclinical Data
Premium
Company Announcements
Rani Therapeutics Highlights Promising Preclinical Data
5M ago
RANI
Rani Therapeutics: Strategic Progress and Promising Pipeline Justify Buy Rating
Premium
Ratings
Rani Therapeutics: Strategic Progress and Promising Pipeline Justify Buy Rating
5M ago
RANI
Rani Therapeutics Faces Nasdaq Compliance Challenge
PremiumCompany Announcements
Rani Therapeutics Faces Nasdaq Compliance Challenge
5M ago
8K
RANI
Rani Therapeutics Board Restructures After DeBuono’s Retirement
PremiumCompany Announcements
Rani Therapeutics Board Restructures After DeBuono’s Retirement
5M ago
8K
RANI
Rani Therapeutics management to meet virtually with Lake Street
PremiumThe Fly
Rani Therapeutics management to meet virtually with Lake Street
6M ago
RANI
Rani Therapeutics Holdings: Buy Rating Backed by Strong Financial Position and Promising Clinical Trials
PremiumRatings
Rani Therapeutics Holdings: Buy Rating Backed by Strong Financial Position and Promising Clinical Trials
6M ago
RANI
Rani Therapeutics: Promising Preclinical Data and Strong Financials Justify Buy Rating
PremiumRatingsRani Therapeutics: Promising Preclinical Data and Strong Financials Justify Buy Rating
6M ago
RANI
Rani Therapeutics Earnings Call: Tech Gains Amid Financial Strains
Premium
Company Announcements
Rani Therapeutics Earnings Call: Tech Gains Amid Financial Strains
6M ago
RANI
Rani Therapeutics’ RT-114: A Promising Contender in the $100 Billion Obesity Treatment Market
Premium
Ratings
Rani Therapeutics’ RT-114: A Promising Contender in the $100 Billion Obesity Treatment Market
6M ago
RANI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >